Glenmark Tells Fed. Circ. Bayer Fell Short In Finacea IP Suit
Glenmark asked a Federal Circuit panel Friday to reverse a Delaware federal judge's finding that it infringed rival Bayer's Finacea rosacea treatment patent, saying Bayer failed to show how Glenmark's competing...To view the full article, register now.
Already a subscriber? Click here to view full article